Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 594
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2401Fatty acid synthaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2402Adenosine deaminaseRNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2403CYP450-IIBRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2404CYP450-IICRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2405CYP450-IIC17RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2406CYP450-IIE1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2407P450 mRNA encoding nifedipine oxidaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2408Cholesterol side chain cleavage enzyme P450RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2409Lanosterol 14-demethylase cytochrome P450RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2410Glutathione S-transferase θ1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2411Glutathione S-transferaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2412Glutathione S-transferase M3RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2413Glutathione S-transferase θ2RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2414Monoamine oxidase ARNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2415Chlordecone reductaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2416Dihydropteridine reductaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2417Zeta-crystallin/quinone reductaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2418Ubiquinol-cytochrome c reductase subunitRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2419IGF2ProteinHumanUpregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2420ADAM9ProteinHumanUpregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2421STAT3ProteinHumanUpregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2422SOCS3ProteinHumanUpregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2423cyclin D1ProteinHumanUpregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2424COL1A1ProteinHumanDownregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2425SMAD4ProteinHumanDownregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2426FHITProteinHumanDownregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2427SOCS1ProteinHumanDownregulated in HCC than normal DiagnosticHCC v/s normal (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51)Tissue14517841
2428IGFBP7Protein and RNAsHumanDownregulated in IFN-resistant cells (with fold change 2.963) PredictiveIGFBP7-positive HCC patients v/s IGFBP7-negative HCC patients p < 0.05Cell line and Tissue20407444
2429reticulon 4 or RTN4RNAsHumanDownregulated in HCC than non-tumor (with fold change of 2.8) DiagnosticHCC v/s non-tumor p < 0.05Tissue16463013
2430RGS-1RNAsHumanDownregulated in HCC than non-tumor (with fold change of 8.5) DiagnosticHCC v/s non-tumor p < 0.05Tissue16463013
2431antiplasminRNAsHumanDownregulated in HCC than non-tumor (with fold change of 3.2) DiagnosticHCC v/s non-tumor p < 0.05Tissue16463013
2432kallikrein BRNAsHumanDownregulated in HCC than non-tumor (with fold change of 10.5) DiagnosticHCC v/s non-tumor p < 0.05Tissue16463013
2433AURKBRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.36 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2434AZI1RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.46 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2435LOC654342RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.58 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2436TPRRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.86 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2437CENPIRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.69 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2438CBX1RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.68 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2439CCHCR1RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.57 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2440STMN1RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.52 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2441AUP1RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.33 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2442IQGAP3RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.24 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2443NFYARNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.41 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2444TH1LRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.54 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2445SLC39A4RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 4.42 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2446MEIS2RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.28 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2447CITRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.26 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2448KIAA0286RNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.99 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2449FAM48ARNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.83 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2450CCNFRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.72) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top